Online citations, reference lists, and bibliographies.

Complications And Diffusion

Matteo C. Lopiccolo, Farhaad R Riyaz, David Ozog
Published 2017 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1046/j.1524-4725.2003.29130.x
Festoon Formation After Infraorbital Botulinum A Toxin: A Case Report
Mitchel P. Goldman (2003)
10.1046/j.1365-2133.2001.04349.x
Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients.
Peter Schnider (2001)
10.1093/qjmed/hcq171
Acute myocardial infarction after botulinum toxin injection.
Barbara E. Stähli (2011)
10.1097/DSS.0000000000000569
Complications in the Cosmetic Dermatology Patient: A Review and Our Experience (Part 1)
Monique Vanaman (2016)
10.1067/mjd.2001.118342
Severe, intractable headache after injection with botulinum a exotoxin: report of 5 cases.
M. Alam (2002)
10.1001/archfacial.2009.5
Long-term safety and efficacy of a new botulinum toxin type A in treating glabellar lines.
Ronald L. Moy (2009)
10.1097/01.iop.0000203304.22031.b5
Diplopia associated with the cosmetic use of botulinum toxin a for facial rejuvenation.
Petros Aristodemou (2006)
10.1046/j.1524-4725.2003.29129.x
Complications, Adverse Reactions, and Insights With the Use of Botulinum Toxin
A. Klein (2003)
10.1046/j.1365-2133.2002.49101.x
Botulism-like syndrome after botulinum toxin type A injections for focal hyperhidrosis.
V. Tugnoli (2002)
10.1111/j.1524-4725.2005.31071
Double‐Blind, Randomized, Placebo‐Controlled Pilot Study of the Safety and Efficacy of Myobloc (Botulinum Toxin Type B) for the Treatment of Palmar Hyperhidrosis
L. Baumann (2005)
10.1136/jnnp.72.4.459
Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia
D. Ranoux (2002)
10.1046/j.1524-4725.2002.02039.x
Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Palmar Hyperhidrosis: A Double‐Blind, Randomized, Placebo‐Controlled Study
N. Lowe (2002)
10.1046/j.1524-4725.2003.29132.x
A Double‐Blinded, Randomized, Placebo‐Controlled Pilot Study of the Safety and Efficacy of Myobloc (Botulinum Toxin Type B)‐Purified Neurotoxin Complex for the Treatment of Crow's Feet: A Double‐Blinded, Placebo‐Controlled Trial
L. Baumann (2003)
10.1136/jnnp.62.2.198
Generalised botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of two cases.
A. Bakheit (1997)
10.1001/archdermatol.2009.128
Increasing the field effects of similar doses of Clostridium botulinum type A toxin-hemagglutinin complex in the treatment of compensatory hyperhidrosis.
Doris Hexsel (2009)
10.1136/bmj.323.7313.596
Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial
M. Naumann (2001)
10.1111/j.1524-4725.2006.32339.x
Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter?
Alastair Carruthers (2007)
10.1111/j.1524-4725.2006.32330.x
Pilot study comparing the diffusion of two formulations of botulinum toxin type A in patients with forehead hyperhidrosis.
A. R. Trindade de Almeida (2007)
10.1007/BF00941758
Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm
Zita Nüβgens (1997)
10.1111/J.1524-4725.2007.34008.X
A Randomized Pilot Study Comparing the Action Halos of Two Commercial Preparations of Botulinum Toxin Type A
D. Hexsel (2008)
10.1097/PRS.0b013e318170813c
Comparisons among Botulinum Toxins: An Evidence-Based Review
Arnold William Klein (2008)
10.1056/NEJM199104253241707
Therapeutic uses of botulinum toxin.
J. Jankovic (1991)
10.1097/01.PRS.0000144795.76040.D3
Consensus recommendations on the use of botulinum toxin type a in facial aesthetics.
Jean D A Carruthers (2004)
10.1001/archderm.140.11.1351
Effect of volume and concentration on the diffusion of botulinum exotoxin A.
T. Hsu (2004)
10.1001/archderm.144.12.1657
Intrafollicular orifice injection technique for botulinum toxin type A.
T. Lewis (2008)
10.1017/CBO9780511544842.015
Clinical Uses of Botulinum Toxins: Cosmetic uses of botulinum toxin A
Kenneth D. Beer (2007)
10.1111/j.1365-2133.2003.05620.x
A double-blind, randomized, comparative study of Dysport vs. Botox in primary palmar hyperhidrosis.
M. Simonetta Moreau (2003)
Treatment of purpura with lasers and light sources.
Laurel M Morton (2013)
10.1111/j.1524-4725.1998.tb04095.x
Botulinum A Toxin for Glabellar Wrinkles: Dose and Response
C. Hankins (1998)
10.1111/dsu.12188
Analysis of Botulinum Toxin Products and Litigation in the United States
John B. Korman (2013)
10.1159/000048297
Effect of Botulinum Toxin A on Facial Wrinkle Lines in Koreans
H. Lew (2002)
10.1046/j.1524-4725.2003.29124.x
Botulinum Toxin Type B (MYOBLOC) Versus Botulinum Toxin Type A (BOTOX) Frontalis Study: Rate of Onset and Radius of Diffusion
Timothy Corcoran Flynn (2003)
10.1067/mjd.2002.124070
Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet.
N. Lowe (2002)
10.1001/archdermatol.2009.343
A simple solution to the common problem of ecchymosis.
Julie K. Karen (2010)
10.1097/PRS.0b013e31816de8d0
Advances in Facial Rejuvenation: Botulinum Toxin Type A, Hyaluronic Acid Dermal Fillers, and Combination Therapies–-Consensus Recommendations
Jean D A Carruthers (2008)
10.1520/JFS2004196
Fatal case of BOTOX-related anaphylaxis?
M. Li (2005)
10.1016/S0733-8635(03)00071-8
Botulinum toxin type A for the treatment of glabellar rhytides.
A. Carruthers (2004)
10.1016/S0190-9622(96)90016-X
Botulinum A exotoxin use in clinical dermatology.
A. Carruthers (1996)
10.1136/jnnp.67.1.90
Generalised muscular weakness after botulinum toxin injections for dystonia: a report of three cases
K. Bhatia (1999)
10.1111/j.1524-4725.2006.32333.x
Dose-finding, safety, and tolerability study of botulinum toxin type B for the treatment of hyperfunctional glabellar lines.
A. Carruthers (2007)
10.1046/j.1524-4725.2002.02037.x
Botulinum Toxin Type B for Glabellar Wrinkles: A Prospective Open‐Label Response Study
Neil S Sadick (2002)
10.1016/j.jaad.2003.11.084
A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines.
B. Ascher (2004)
10.1097/01.PRS.0000076504.79727.62
Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Botulinum Toxin Type A for Patients with Glabellar Lines
J. Carruthers (2003)
10.1111/j.1524-4725.1998.tb04103.x
Cosmetic Use of Botulinum A Exotoxin for the Aging Neck
F. Brandt (1998)



Semantic Scholar Logo Some data provided by SemanticScholar